Tomorrow’s meeting
What do you think will be elaborated on for tomorrow’s meeting?
The discussion points are:
2026 Mid-Year Progress: Overall updates on company milestones and vision.
CNSide Launch: Updates on the commercial rollout of their diagnostic platform.
Reyobiq Development: Clinical and operational plans for their lead drug candidate.
CNS Oncology Strategy: Integration of their therapeutic, diagnostic, and bioinformatic pipelines.
Native AI Plans: Current and future development plans for their AI data strategies.
What questions would you all like to ask?